This lecture-based, 2.5-hour live webinar course covers 21 CFR Parts 210, 211, and 600. Topics include the current Good Manufacturing Practices (cGMPs), regulatory compliance, and maintaining a culture of quality for the safe manufacture of biopharmaceutical drug products. Participants learn the core precepts of the FDA’s current Good Manufacturing Practices and their direct application to the manufacture and testing of a regulated biological product.
Attendees will be able to:
· understand the purpose and impact of cGMP protocols and regulatory compliance
· recall the history of cGMP and the role of the FDA
· recognize legislation, definitions, and critical components of cGMP in biological drug development
· comprehend the FDA cGMP Regulations as defined in 21 CFR 210, 211, and 600
This course will be available live online on Wednesday, July 13, 2021, 9:30am-12:00pm ET